Senior insider sale
Chief Medical Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$407.8K
16.61K shares
What this filing means
WELGUS HOWARD G. plans to sell 16.61K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $407.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2026ACC: 0001628280-26-048326
Officer· Chief Medical Officer
Since Jan 2020
16.61K
Shares to sell
$407.8K
Approx. market value
4.73K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months4
Restricted Stock Vesting
NA
6/4/2026
634.00Stock Option Exercise
Cash
6/14/2024
2.25KStock Option Exercise
Cash
5/31/2023
1.02KStock Option Exercise
Cash
11/20/2019
822.00Total acquired4.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2026 | Restricted Stock Vesting NA | 634.00 | — |
6/14/2024 | Stock Option Exercise Cash | 2.25K | — |
5/31/2023 | Stock Option Exercise Cash | 1.02K | — |
11/20/2019 | Stock Option Exercise Cash | 822.00 | — |
| Total | 4.73K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
635.00
Market value
$16.3K
6/17/2026
—Completed
Units to sell
4.10K
Market value
$100.0K
6/15/2026
—Completed
Units to sell
7.14K
Market value
$164.2K
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.73K
Market value
$127.3K
7/15/2026
Total
Units
16.61K
Value
$407.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2026 | 635.00 | $16.3K | — | Completed |
6/15/2026 | 4.10K | $100.0K | — | Completed |
5/1/2026 | 7.14K | $164.2K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 4.73K | $127.3K | NASDAQ | Planned |
| Total | 16.61K | $407.8K | ||